Lilly receives MHRA authorisation in Great Britain for tirezepatide (MOUNJARO ®▼) in alternative Kwikpen® presentation for two indications

The Medicines and Healthcare products Regulatory Agency has granted marketing authorisation in the UK for tirzepatide solution for injection in an alternative KwikPen® presentation for two indications.